Securities code: Vcanbio Cell & Gene Engineering Corp.Ltd(600645) securities abbreviation: Vcanbio Cell & Gene Engineering Corp.Ltd(600645) Announcement No.: 2022013 Vcanbio Cell & Gene Engineering Corp.Ltd(600645)
Announcement on the resolutions of the 16th extraordinary meeting of the 10th board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Vcanbio Cell & Gene Engineering Corp.Ltd(600645) (hereinafter referred to as “the company”) the 16th interim meeting of the 10th board of directors was held by means of communication voting on March 26, 2022. The meeting notice and meeting materials have been sent to all directors by e-mail on March 21, 2022. There are 9 directors who should attend the meeting and 9 directors who actually attend the meeting. The meeting complies with the provisions of the company law and the articles of association, and the voting is valid. After careful deliberation by the directors present at the meeting, the following resolutions were adopted:
1. The proposal on the election of the chairman of the 10th board of directors of the company was deliberated and adopted with 9 votes in favor, 0 votes against and 0 abstentions, and Mr. Gong Hongjia was elected as the chairman of the 10th board of directors of the company.
Resume of Mr. Gong Hongjia
Male, 57, Bachelor of computer science, Huazhong University of science and technology.
He is currently a director of Furong Technology Co., Ltd., chairman of Hangzhou Fuxin Zhangjing Technology Co., Ltd., chairman of the board of directors of Funian Technology Co., Ltd., chairman of Beijing Funian Technology Co., Ltd. Shanghai Fullhan Microelectronics Co.Ltd(300613) director, director of Shenzhen innovation Valley Investment Management Co., Ltd., director of fuce Holdings Co., Ltd., director of Chuangjia Venture Capital Co., Ltd., general manager of Shenzhen jiadaogu Investment Management Co., Ltd Appointed representative of executive partner of Shenzhen Jiadao Gongcheng equity investment fund (limited partnership), director of 981 Health Technology Group Co., Ltd., director of Beijing jiabowen Biotechnology Co., Ltd., director of Wuhan Youxin Technology Co., Ltd., director of Qingke Management Consulting Group Co., Ltd., appointed representative of executive partner of Shenzhen Jiadao Fangzhi education industry investment enterprise (limited partnership) Appointed representative of the executive partner of Shenzhen Jiadao successful investment enterprise (limited partnership), chairman of Sichuan Jiadao Bowen Ecological Technology Co., Ltd., supervisor of Beijing jiadaogu Management Consulting Co., Ltd., director of Shenzhen Zhongke scientific and technological achievements transformation Equity Investment Fund Management Co., Ltd., chairman of Shanghai Aoyuan medical supplies Co., Ltd., director of Sichuan Huiyang life Engineering Co., Ltd Director of Shenzhen xishima Data Technology Co., Ltd., director of Beijing nutshell universe Education Technology Co., Ltd., chairman of Guangzhou Funian Electronic Technology Co., Ltd., director of Tianjin Development Zone Deyuan Investment Development Co., Ltd., vice chairman of Yongtai Honghe Holding Group Co., Ltd., director of Shenzhen guotengan Vocational Education Technology Co., Ltd. and director of Shenzhen carbon cloud Holding Co., Ltd. He once served as Hangzhou Hikvision Digital Technology Co.Ltd(002415) vice chairman, director of Xinyuan Microelectronics (Shanghai) Co., Ltd., chairman of Sichuan five plus one Ecological Agricultural Technology Service Co., Ltd., chairman of Sichuan jiabowen Biotechnology Co., Ltd., chairman of Shenzhen Zhongke scientific and technological achievements transformation Equity Investment Fund Management Co., Ltd. and director of Shanghai pukun Information Technology Co., Ltd.
2. With 9 affirmative votes, 0 negative votes and 0 abstention, the proposal on adding members of professional committees of the 10th board of directors of the company was deliberated and adopted;
After deliberation and approval by the general meeting of shareholders, the company added directors to the 10th board of directors. In accordance with the provisions of the company law and the articles of association, the company convened the board of directors to supplement the members of each professional committee of the 10th board of directors.
After the addition, the composition of each professional committee is as follows:
(1) Strategy Committee
Chairman: Gong Hongjia; Members: Wang Xuehai, Wang Yong, Wu Shan, Pei duanqing
(2) Audit Committee
Chairman: Chen Min; Members: Hou Xinyi, Wu Shan
(3) I. Nomination Committee
Chairman: Pei duanqing; Members: Chen Min, Gong Hongjia
(4) , salary and assessment committee
Chairman: Hou Xinyi; Members: Pei duanqing, Gong Hongjia
3. With 9 votes in favor, 0 against and 0 abstention, the proposal on using idle raised funds to temporarily supplement working capital was deliberated and adopted.
For details, see the announcement on temporarily replenishing working capital with idle raised funds on the same day. It is hereby announced.
Vcanbio Cell & Gene Engineering Corp.Ltd(600645) board of directors March 28, 2002
